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ABSTRACT
In the fission yeast Schizosaccharomyces pombe, the
cdc11 gene is required for the initiation of septum
formation at the end of mitosis. The sce3 gene was
cloned as a multi-copy suppressor of the heat-sensitive
mutant cdc11-136. When over-expressed, it rescues all
mutants of cdc11 and also a heat-sensitive allele of
cdc14, but not the cdc14 null mutant. Deletion shows
that sce3 is not essential for cell proliferation. It
encodes a putative RNA-binding protein which shows
homology to human eIF4B. Immunolocalisation
indicates that Sce3p is located predominantly in the
cytoplasm. Elevated expression of sce3 increases the
steady-state level of cdc14 mRNA. Possible mechan-
isms of its action are discussed.
INTRODUCTION
The fission yeast Schizosaccharomyces pombe provides a simple
eukaryotic system to study the control of cytokinesis and its
co-ordination with mitosis (1). Fission yeast cells grow mainly by
elongation at their tips, and divide by binary fission after forming
a centrally placed septum. As in higher eukaryotes, initiation of
cytokinesis is dependent upon the onset of mitosis (2). In S.pombe,
F-actin is seen as patches or dots at sites of cell growth or division.
During interphase, it is found at the growing ends of the cell, and,
after the onset of mitosis, it relocates to form an equatorial ring
whose position anticipates the site of septum formation (3,4). The
septum grows inwards from the cell cortex at the end of mitosis,
when the spindle breaks down. Secondary septa are formed on
either side of the primary septum, which is then dissolved to bring
about cell separation. F-actin is then relocated to the old
(pre-existing) end of the cell, from where growth resumes.
Some of the proteins which control the onset of septum
formation and cytokinesis in fission yeast have been identified.
The products of the arp3, sop2, cdc3, cdc4, cdc8, cdc12, cdc15
and rng2 genes are required for actin rearrangement and/or to
stabilise the actin ring (5–13). The dmf1 protein is implicated in
assuring correct positioning of the medial ring: mutants of the
dmf1/mid1 gene misplace the division septum at high frequency
(12,14). Immunofluorescence studies have shown that the
products of the dmf1, cdc3, cdc4, cdc8, cdc12 and cdc15 genes are
associated with the medial ring (6,7,9,10,12–14).
At the end of mitosis, the Cdc7p kinase, the Spg1p GTPase and
the activities of Cdc11p and Cdc14p are required for septation
(5,15–17). A conditional, heat-sensitive mutation in any of these
genes results in the failure to make a division septum, though
F-actin ring formation is not impaired (9,17). Cells become highly
elongated and multinucleate, as growth and nuclear division
continue in the absence of cell division. Spg1p and Cdc7p interact
directly (17), and genetic evidence suggests that cdc11 and cdc14
are part of the same complex responsible for regulating septum
formation (18). The plo1 kinase appears to be required for both
actin ring formation and septation, and increased expression can
induce septum formation from G1 and G2 (19). Once septation
has been initiated, the products of the cdc16 and byr4 genes are
required to limit the cell to making a single septum per cell cycle
(2,20,21). Cloning and characterisation of the cdc11 gene would
further our understanding of the mechanisms responsible for the
induction of septum formation, and its co-ordination with mitosis.
To date, we have not been successful in cloning cdc11; however,
we isolated several multi-copy suppressors. The characterisation
of one of these, sce3, is presented here.
MATERIALS AND METHODS
Yeast physiological and genetic techniques
Standard techniques were used for growth, manipulation and
synchronisation of fission yeast (22). Cells were grown in yeast
extract (YE), malt extract (ME) or EMM2 minimal medium,
supplemented as required with 50 mg/ml of adenine, uracil,
leucine, histidine or lysine. The vitality stain Phloxin B (Sigma)
was added to YE or EMM2 medium at a concentration of 5 mg/ml,
to identify diploid or mutant cells on plates. Selection synchrony
was performed as described (17), using a Beckman JS 5.0
elutriation system. Cell number was measured with a Coulter
counter and the percentage of septated cells was determined by
staining with Calcofluor. Other techniques have been referred to
previously (9). The yeast strains used in this study are listed in
Table 1. All mutants were outcrossed to wild-type at least twice
before use. Crosses were performed on ME plates at 25C,
according to (23), and the resulting tetrads were dissected using
a Leitz micromanipulator.
All transformations of S.pombe cells were performed by the
lithium acetate method, unless stated otherwise (24). To induce
expression of genes under the control of the thiamine repressible
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nmt1 promoter, in strains carrying either a pREP vector (pREP3,
pREP41, pREP81) (25,26) or the pINT5 integrated vector (as
described in 16), cells were grown to mid-exponential phase in
EMM2 medium containing 2 mM thiamine. They were then
collected by centrifugation, washed twice in sterile water and
reinoculated into EMM2 medium lacking thiamine. At 25C,
under these conditions, the promoter is induced after 12–13 h.
Table 1. List of strains used in this study
Strain Genotype Reference
SP0007 leu1-32 h– (5)
SP0560 ade6M210/ade6M216 leu1-32/leu1-32 This study
ura4D18/ura4D18 h+/h–
SP0699 cdc11-136 leu1-32 h– This study
SP0701 cdc11-136 ura4D18 h– This study
SP0763 cdc14-118 leu1-32 h– (15)
SP1387 sce3::ura4+/sce3+ ade6M216/ade6M216 h90 /h+ This study
SP1397 sce3::ura4+ h– This study
SP1680 leu1::pint5(ura4+)-sce3 ura4D18 h– This study
The source of each original mutant is given. Auxotrophic markers (leu1-32,
ura4D18, ade6M210 or ade6M216) were crossed into the backgrounds as required.
Expression cassettes based upon pINT5 were introduced into backgrounds
either by transformation of DNA fragments, or by appropriate genetic crosses.
Molecular biology techniques
Standard methods were used throughout for DNA and RNA
manipulations (27). Sequencing was performed by the dideoxy
chain termination method on both strands, using the Sequenase
2.0 Kit (United States Biochemical Corp.), and Exonuclease III
deletions were done with the ‘Erase-a-base’ Kit (Promega),
according to the manufacturer’s instructions. Techniques for
S.pombe plasmid recovery and DNA and RNA extractions have
been described (22). Northern and Southern blots were performed
by capillary transfer onto GeneScreen Plus membranes (NEN),
hybridisation and washing of the filters were done according to
the manufacturer’s protocol. Probes were made by random
hexamer priming (27).
Cloning of the sce3 gene
Schizosaccharomybes pombe strain SP0701, cdc11-136 ura4D18
h– , was transformed to uracil prototrophy by the protoplast
method (28), using a wild-type S.pombe genomic DNA library,
based on the pUR18 vector (29). Transformants were replica-
plated onto minimal medium containing Phloxin B, at 36C. Six
plasmids were rescued from colonies able to grow at the
restrictive temperature. The sce3 cDNA was isolated from a
wild-type S.pombe cDNA library (30), by hybridisation with the
ClaI–HindII fragment, and sequencing confirmed the presence of
the three introns.
Deletion of the sce3 gene
To create a sce3 null allele, the BglII–BglII fragment of the
genomic clone, encompassing the whole sce3 ORF, was replaced
by the S.pombe ura4+ gene (Fig. 1A). This plasmid was then cut
with EcoRI and the resulting 4.4 kb fragment was gel-purified and
used to transform the diploid strain SP0560 to uracil prototrophy,
Figure 1. Structure of sce3 locus and sequence of Sce3p. (A) Representation
of the sce3 locus. Some relevant restriction sites are shown. The black bars
represent the positions of the four exons of the sce3 gene. The BglII–BglII
fragment replaced by the ura4+ gene to make the sce3 null allele is also shown.
The bars below the gene structure indicate subclones of sce3 tested for their
ability to complement cdc11-136. Open bars indicate that a clone is able to
rescue, solid bars indicate that it cannot. (B) The predicted protein sequence of
Sce3p is shown, using the one-letter code for amino acids. The residues
conserved in the RNP domain are underlined. The asterisk represents a STOP
codon.
creating the diploid (SP1387). Chromosomal DNA was extracted
from wild-type diploid cells (SP0560), from the diploid hetero-
zygous for the sce3 deletion (SP1387), and from the four resulting
spores, and was digested with EcoRI. The disruption was verified
by Southern blotting, using the ura4+ gene and the BglII fragment
of sce3 as probes.
Schizosaccharomyces pombe protein extracts
Protein extracts were performed using a slightly modified version
of the previously described method (16). Schizosaccharomyces
pombe cells were collected and washed in ice-cold STOP buffer
(0.9% NaCl, 1 mM NaN3, 10 mM EDTA, 50 mM NaF). Cells
were lysed with 1 ml of acid washed beads (Sigma), by vortexing
2 min at 4C, in the presence of a modified extraction buffer (60 mM
β-glycerolphosphate, 25 mM MOPS pH 7.2, 15 mM MgCl2,
15 mM EGTA, 1 mM DTT, 0.1 mM sodium orthovanadate, 1 mM
PMSF, 20 µg/ml leupeptin, 40 µg/ml aprotinin). Concentration of
proteins was determined using the BioRad Protein Assay Kit.
Production of antisera and Western blotting
The HincII–BglII C-terminal fragment of sce3 was cloned into a
SmaI-digested pGEX-3X plasmid to produce a GST fusion
protein. This part of the protein lacks the two putative RNA-binding
motifs. Escherichia coli DH5α cells were transformed with this
construct, and induced to produce the fusion protein by addition
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Figure 2. Alignment of Sce3p with related proteins from the sequence databases. (A) The single RNP domain of Sce3p is aligned with the single domain in human
eIF4B, S.cerevisiae TIF3, human KIAA0038, the four domains of human PAB1 and the two domains of human U1A. Conserved residues are shown on a black
background, while conservative substitutions are shaded in grey. Gaps were introduced as required to maximise homology. Abbreviations: SP, S.pombe; HS, human;
SC, S.cerevisiae. (B) Homology between Sce3p, human eIF4B and KIAA0038 in the domain C-terminal to the RNP motif. Abbreviations and homologies are coded
as in (A).
of IPTG to 0.1 mM. After an additional 3 h growth at 37C, cells
were collected by centrifugation. The bacterial pellet was
resuspended in ice-cold PBS (phosphate-buffered saline) pH 7.2,
containing 50 µg/ml leupeptin, 1% (v/v) aprotinin, 1 mM PMSF
(phenylmethylsulfonyl fluoride) and 1% (v/v) Triton X-100,
sonicated, and then centrifuged 10 min at 10 000 g. The supernatant
was then passed through a glutathione–agarose column equilibrated
in the same buffer, containing protease inhibitors as described.
The protein was eluted from the column with 5 mM reduced
glutathione. As degradation products were also eluted by this
method, the proteins were finally separated on a 10% sodium
dodecyl sulfate (SDS) polyacrylamide gel. Proteins were visualised
by incubating the gel in ice-cold 0.25 M KCl. The fusion protein
band was excised, and the protein was electroeluted in 15 mM
Tris base, 72 mM glycine, 0.05% (w/v) SDS, pH 8.3.
A rabbit (New Zealand White) was injected intramuscularly at
monthly intervals with 150–200 µg of protein emulsified in
incomplete Freund’s adjuvent. The serum was affinity purified
according to standard procedures (31). SDS–PAGE and Western
blots were performed onto nitrocellulose as described (31). The
affinity purified sce3 antibodies were used at 1/10 000 dilution.
Bound antibodies were detected using peroxidase-coupled second-
ary antibodies and revealed with ECL (Amersham), or with
alkaline phosphatase-coupled secondary antibodies, at a 1/7500
dilution.
Microscopy
Staining with DAPI (4′-6′ diamidino-2-phenylindol, Sigma), Calco-
fluor (Fluorescent Brightener N28, Sigma) and rhodamine-
conjugated phalloidin was performed as described (3). Tubulin
was detected as described (32) using TAT-1 (33), diluted 1/50.
The sce3 affinity purified polyclonal antibody was used at a 1/100
dilution, after fixation of cells with 4% PFA. The secondary
antibody was goat anti-mouse or goat anti-rabbit IgG, CY3
conjugated, used at a dilution of 1/800 and 1/400, respectively.
Photographs were taken using a Zeiss Axiophot microscope with
×100 objective onto Kodak Tri-X Pan film and processed
according to the manufacturer’s protocol.
RESULTS
Cloning of the sce3 gene
To try to clone the cdc11 gene by complementation, the strain
cdc11-136 ura4D18 was transformed to uracil prototrophy with
a wild-type S.pombe genomic DNA library (Materials and
Methods). Colonies were allowed to form at 25C on selective
medium, replica plated to 36C, and plasmids were recovered
from colonies able to grow at the restrictive temperature. Three
different genes were isolated from this screen, one of which, sce3,
is discussed here. Hybridisation against an ordered cosmid library
(34) mapped sce3 to cosmid 16C3, close to the centromere of
Chromosome II. The cdc11 gene is known to be located near the
rDNA cluster on Chromosome III, at the opposite end to ura4.
Thus, sce3 is a multicopy suppressor of cdc11-136.
Three structurally related plasmids were recovered, and one
with a 5.2 kb insert was used for restriction mapping and further
analysis (Fig. 1A). A combination of unidirectional exonuclease
III deletions and subcloning of convenient restriction fragments
was used to define a 2.1 kb region responsible for the rescue of
cdc11-136. The gene found in this region was named sce3
(suppressor of cdc eleven). Sequencing of the sce3 genomic DNA
and cDNA indicated the presence of three introns at the 5′ end of
the coding sequence. The accession number for the DNA
sequence in the EMBL database is AJ000318. Sce3 rescues all
three tested alleles of cdc11 (cdc11-119, cdc11-123, cdc11-136),
and also rescues the cdc14-118 mutant but not a cdc14 null allele.
However, increased expression of sce3 does not rescue cdc7-24,
cdc15-140, cdc16-116 or mutants of cdc2.
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Figure 3. Deletion of sce3 indicates that it is not an essential gene. (A) DNA
was extracted from SP0560 (+/+), SP1387 (+/∆), SP1397 (∆) and SP0328
(wild-type) strains. The DNA was digested and probed with either a sce3 probe
or a ura4 probe (as described in Materials and Methods) on a Southern blot.
Note that there is no sce3 signal in the haploid null mutant. In the blot probed
with ura4, only the two strains carrying the deletion show a band. (B) Cells from
strain SP1397, a haploid strain carrying the sce3 null allele, were fixed and
stained with DAPI, rhodamine conjugated phalloidin or the TAT-1 antibody.
The sce3 gene encodes a protein of 388 amino acids, with a
calculated molecular weight of 42680, whose sequence is shown
in Figure 1B. Database comparisons revealed the presence of an
RNP domain in the N-terminal region of the protein. The RNP
domain is known to be involved in binding RNA. An alignment
of the Sce3p RNP domain with those most similar to it is shown
in Figure 2A. Overall, Sce3p is most homologous to human
Initiation Factor 4b (eIF4b). In addition to the RNP domain the
homology extends into the C-terminal region (Fig. 2B), which
was shown, in the case of eIF4b, to be implicated in binding RNA
(35,36). Interestingly, C-terminal truncations of sce3 tested for
their ability to complement a cdc11-136 mutant (Fig. 1A)
implicate this C-terminal region as important for sce3 function,
since fragments lacking it but still containing both RNP motifs are
not able to rescue a cdc11-136 strain.
Sce3 is not essential for cell proliferation
To determine whether the sce3 gene is essential for cell
proliferation, one copy of the entire coding sequence was replaced
by the ura4+ gene in a diploid strain (Fig. 1A; Materials and
Figure 4. The Sce3 mRNA level is constant in exponential growth, but decays
rapidly in response to starvation. (A) Cells were synchronised by elutriation and
small G2 cells were reinoculated into fresh medium at 36C. Samples were
taken every 15 min. Cell number was determined using a Coulter Counter and
the percentage of septated cells by dark field microscopy. RNA extracts were
prepared at each timepoint and Northern blotted. The blot was probed either
with a sce3 BglII–BglII fragment or with a fragment of H2A, as control.
(B) Cells were grown to mid-exponential phase in minimal medium and then
washed twice and reinoculated into a medium lacking nitrogen. Samples were
taken every 30 min or every hour following the medium-shift. RNA was
extracted and Northern blotted, and probed with a sce3 probe [same fragment
then in (A)] or with a ura4 HindIII–HindIII fragment.
Methods). Correct replacement was verified by Southern blot
analysis (Fig. 3A). After sporulation and tetrad dissection, all four
spores in each tetrad were able to form a colony, and the ura4+
gene segregated 2:2, indicating that sce3 is not essential for cell
division. The sce3::ura4+ null mutant showed no heat or cold
sensitivity when compared to an otherwise isogenic wild-type strain,
and divided at a similar rate to wild-type (not shown). Staining of
sce3::ura4+ cells with rhodamine-conjugated phalloidin, to
reveal the F-actin, and TAT-1, to reveal microtubules, showed that
they are indistinguishable from wild-type cells. F-actin rings were
clearly observed prior to septum formation, and microtubules
were seen in either the typical interphase array, or as short mitotic
spindles (Fig. 3B). Thus, loss of sce3 function interferes neither
with cell division, nor with the normal cytoskeletal rearrangements
that occur during the cell cycle.
Double mutants between sce3::ura4+ and other mutants
implicated in septum formation were created by tetrad dissection.
Genetic interactions were observed only in the case of
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Figure 5. An antiserum to Sce3p recognises a 43 kDa protein. Proteins were
extracted from either SP1397 cells (lane 1), SP0007 cells (lane 2), SP0573 cells
(lane 3) or SP1680 cells (lane 4). The Western blot was probed with either
affinity purified antibody to Sce3p, or with TAT-1, as loading control. Note the
missing Sce3p band in the sce3 null allele (lane 1), and the strong band in cells
overexpressing (lane 4).
sce3::ura4+ cdc11-136 and sce3::ura4+ cdc14-118, where the
restrictive temperature was lowered by 2–3C as compared to
each single mutant. No additive effects were observed with all
other mutants tested (cdc7-24, cdc15-140, cdc16-116).
Sce3 mRNA level is constant in exponential growth but
decays rapidly in response to nitrogen starvation
We tested if the sce3 transcript varied in its level during the cell
cycle. A culture of wild-type cells was synchronised by elutriation
and small, G2 cells were reinoculated into fresh medium. Samples
were taken at the indicated times after reinoculation, RNA
extracts were prepared and analysed on a Northern blot by
hybridisation with a sce3 probe. As shown in Figure 4A, the
steady state level of the sce3 mRNA does not change significantly
through the cell division cycle during exponential growth, while
the H2A control transcript fluctuates, as expected. In contrast,
when RNA is extracted from cells entering stationary phase after
shift to nitrogen-free medium, the steady-state level of sce3
mRNA decreased very rapidly (within 30 min after shift), while
the ura4 control transcript remained constant (Fig. 4B). This
abrupt change in sce3 mRNA level suggests that its function is not
required during exit from the cell cycle.
Immunolocalisation of Sce3p
To localise Sce3p in the cell, a polyclonal antibody directed
against the C-terminus of the protein was produced by immunising
a rabbit (Materials and Methods). After affinity purification, the
antibody recognised a protein of the expected size (43 kDa) on a
Western blot of protein extracts made from wild-type cells. This
band was not detected in extracts from cells deleted for the sce3
gene (Fig. 5) and was much stronger in extracts from cells
containing a multicopy plasmid expressing high levels of the sce3
gene. This confirms that the protein recognised is Sce3p.
Immunolocalisation studies were performed on wild-type cells
(SP0007), cells deleted for sce3 (SP1397) and cells overexpressing
sce3 (SP1680). This showed that Sce3p is predominantly
cytoplasmic at all stages of the cell cycle both in wild-type cells
(Fig. 6A) and in cells overexpressing sce3 (Fig. 6B). No signal
was seen in sce3::ura4+ cells (Fig. 6C), confirming the specificity
of the staining.
Figure 6. Sce3p is predominantly a cytoplasmic protein. (A) Wild-type cells
were grown to mid-exponential phase in EMM2 medium, fixed and stained
with DAPI and CY3 coupled anti-Sce3p antibody (Materials and Methods).
Note that the localisation of Sce3p is predominantly cytoplasmic. (B) Cells
SP1680 were grown in thiamine-free medium for 18 h at 25C to induce Sce3p
expression. Cells were treated as described in (A). (C) Cells deleted for sce3
(SP1397) were processed as in (A). The absence of any signal confirms the
specificity of the anti-Sce3p antibody.
Overexpression of sce3 in wild-type cells does not
impede cell cycle progression
Wild-type cells expressing the sce3 gene from a single integrated
copy under the control of the inducible nmt1 promoter were
grown to mid-exponential phase, and shifted to thiamine-free
medium for 18 h at 25C. Cells were fixed and stained for actin
and tubulin, using rhodamine-conjugated phalloidin and TAT-1
antibody. All the expected cytoskeletal rearrangements occurred
normally: normal spindle and interphase microtubule configurations
were observed. F-actin formed a ring at the onset of mitosis and
was otherwise located at the tips of interphase cells (data not
shown). Thus, cells expressing high levels of Sce3p are indistin-
guishable from wild-type, with respect to cytoskeletal rearrange-
ments.
To test the effect of altering the gene dosage of sce3 upon cdc14
mRNA level, we prepared RNA extracts from wild-type cells,
cdc11-136 cells and cdc14-118 cells, all of them either overexpres-
sing sce3, or not, and from cells deleted for sce3, and analysed
them on a Northern blot with a probe against cdc14 (Fig. 7). This
demonstrated that in all tested backgrounds, the level of cdc14
mRNA was always higher in the presence of high amounts of
Sce3p than in cells with wild-type levels of Sce3p. Quantitation
of the bands using a Phospho-Imager revealed a 2–3-fold increase
in cdc14 mRNA level (data not shown).
DISCUSSION
The sce3 gene was cloned as a multicopy suppressor of a
cdc11-136 mutant. It can also rescue two other alleles of cdc11
and cdc14-118, but none of the other cytokinesis mutants tested.
It does not rescue a cdc14 null allele, so it does not bypass the
requirement for cdc14. We showed that deletion of sce3 renders
cells more sensitive to the cdc11-136 and cdc14-118 mutations,
but has no other effect by the criteria we have tested.
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Figure 7. Cdc14 mRNA level is increased in cells overexpressing sce3. RNA
extracts were prepared and blotted (Materials and Methods) from the following
strains (grown at 36C): wild-type cells (SP0007) (lane 1), cdc11-136 cells
(SP0699) (lane 3) and cdc14-118 cells (SP0763) (lane 5). Immediately adjacent
to each of these lanes is the corresponding strain overexpressing sce3 (lanes 2,
4 and 6). Lane 7 is an RNA extract from cells deleted for sce3 (SP1397). The
Northern blot was probed with a probe recognising cdc14, and a ura4 probe as
loading control. Note the increase in the amount of cdc14 mRNA in each lane
overexpressing sce3 (lanes 2, 4 and 6).
Database comparisons indicate that sce3 contains one RNP
motif in its N-terminal region. RNA-binding proteins often
contain one or more copies of this domain (37–39). Within the
RNP motif, the RNP1 and RNP2 sub-motifs play a crucial role in
RNA-binding, as shown by in vitro mutagenesis (40,41) and the
crystal structure of the domain (42). Based on this, it is likely that
Sce3p will be an RNA-binding protein.
What is the biological function of Sce3p?
RNP motif containing proteins have been implicated in a wide
range of biological processes. Since loss of Sce3p has no overt
phenotype in an otherwise wild-type background, it is not clear
in which event(s) it participates. However, the protein most
homologous to Sce3p, in searches of the sequence databases, is
human eIF4B, which is an RNA-binding protein that binds to, and
stimulates, the RNA helicase eIF4A, thereby promoting the
association of mRNA to the 40S subunit of the ribosome. The
RNA-binding specificity of human eIF4B is conferred both by the
residues within the RNP domain, and in a second RNA-binding
domain located in the C-terminal region of the protein (35,36).
The homology between eIF4B and Sce3p also extends to this
second domain. Interestingly, C-terminal deletions of Sce3p that
still contained both RNP1 and RNP2, but lacked this second
domain, were unable to rescue the cdc11-136 mutant, consistent
with this region being important for Sce3p function. The TIF3
gene is thought to be the Saccharomyces cerevisiae homologue of
eIF4B (43). However, Sce3p is more closely related to eIF4B in
the RNP domain, and Tif3p does not contain the second,
C-terminal RNA-binding region found in sce3 and eIF4B. In this
context, it is interesting to note that S.pombe eIF4E also shares
some features with its human counterpart that are not conserved
in the equivalent gene in S.cerevisiae (44). Both the TIF3 and sce3
null mutants are viable, though the former is cold sensitive (43).
It is therefore possible that Sce3p plays an eIF4B-like role in the
initiation of translation. The lack of observable phenotype for the
sce3 null in a wild-type background, suggests that it is redundant
with another protein for eIF4B function.
Regulation of sce3 at the level of transcription
Exit from the cell cycle and entry into the quiescent G0 state is an
active process that is not yet well understood at the molecular
level (45). During the transition from G1 to G0, cells down-regu-
late some genes required for cell cycle progression, and some
metabolic genes; for example, DNA polymerase and DNA
primase (46), and a subunit of ribonucleotide reductase (47), are
constitutively expressed in cycling cells, but are lost upon exit to
G0. The fact that the steady-state level of the sce3 mRNA
decreases rapidly upon nitrogen starvation suggests that sce3
function is not required upon entry into stationary phase.
Examination of the 3′ untranslated region of the mRNA shows
that it contains a number of U-rich tracts, which have been
implicated as a feature contributing to mRNA instability (48).
Whether this is essential for the rapid degradation of sce3 mRNA
in response to starvation is unknown.
How does increased expression of Sce3p rescue mutants
in cdc11 and cdc14?
It has been proposed that under optimal conditions for translation,
mRNAs are longer-lived (49). If Sce3p functions in the initiation
of translation, its role may be to facilitate the association of a
subset of mRNAs, perhaps including cdc14, with the ribosome.
It is possible that an increased level of Sce3p facilitates
association of the cdc14 mRNA with the ribosome, and thereby
increases the stability of the mRNA. In the absence of any
feedback regulation of the cdc14 mRNA, a decrease in the rate of
degradation will result in an increase in its steady state level.
Alternatively, Sce3p may bind the cdc14 mRNA directly, and
prevent its degradation in a manner independent of translation. In
both cases, the net result will be an increase in the amount of
Cdc14p. Since it is known that cdc14-118 has considerable
residual activity at the non-permissive temperature (5), it is
possible that a small increase in the level of mutant protein
provides sufficient activity to permit cell division. In the absence
of Sce3p the level of cdc14 mRNA does not change, but
cdc14-118 mutant cells have a reduced restrictive temperature: it
is possible that the cdc14 mRNA is translated less efficiently and
so the level of the mutant protein decreases, reducing the total
amount of cdc14 activity, and rendering the cells more heat
sensitive. Whether Sce3p also affects the level of cdc11 mRNA
awaits cloning of the cdc11 gene.
It is clear that there is some specificity in the suppression of cell
cycle mutants by sce3, since it has no effect upon other leaky
mutants, such as cdc7, or upon cdc2 mutants. In the latter case,
two human RNP motif containing proteins (Scr2 and Scr3) were
isolated as suppressors of S.pombe cdc2 and cdc13 mutations
(50). Interestingly, these were also proposed to function by
facilitating the translation of the mutant protein.
Studies of S.cerevisiae have shown that another factor impli-
cated in translation initiation can be a suppressor of conditional
mutants. DED1 encodes an RNA helicase implicated in the
initiation of translation (51). A mutant allele of DED1 has been
identified as a suppressor of a splicing mutant (52), and increased
expression of DED1 can suppress the growth defect of an RNA
polymerase III mutant (53).
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